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Chronic diseases have a high perceived like-
lihood to impact world economic instability in the
next ten years. This was published in the Global
Risks report of the World Economic Forum 2011
with an estimate of likelihood similar to the glo-
bal financial crisis. In the risk interconnection map
(Fig. 1) of this report chronic diseases connect to
climate change and demographic challenges con-
tributing to economic disparity due to the added
burden to health care systems [1].
Chronic respiratory diseases are one of the four
major noncommunicable diseases (NCDs) that are
causing premature death and disability in all co-
untries of the WHO European region. There are an
estimated 8.6 million deaths from NCDs including
1.5 million before the age of 60 years. It is well ac-
cepted now that this rapidly growing epidemic of
all NCDs is affecting populations disproportiona-
tely, and the gaps within health care systems are
growing between and within European countries.
Improved disease management programs are able
to reduce mortality and disability and contribute
to better health care outcomes [2].
In COPD acute exacerbation requiring hospi-
tal care is a cornerstone of increased hospital mor-
tality but also of the reduced survival after dischar-
ge [3, 4]. The pressure of exploding health care co-
sts leads to discussion about standards of care that
are required for adequate disease management in
COPD. For more than 12 years some countries have
started to audit, in a systematic way, the quality of
their COPD management [5, 6]. Huge variations
and inequalities of care were detected revealing
a remarkable impact of the organisation of care on
clinical outcomes of COPD patients after hospita-
lisation. Systematic audit processes led to an im-
provement of standards of care including better re-
source allocation and better clinical standards na-
tionwide.
Based on this experience the European Audit
intended to multiplicate the data collection on or-
ganisation of care and clinical treatment standards
within and between the participating countries.
The pilot project was initiated by the European Re-
spiratory Society (ERS) in collaboration with the
Forum of the European Respiratory Societies
(FERS, the platform of all national societies) with
the aim to compare the quality of care compared
to guideline recommendations and the related or-
ganisation of care (Fig. 2). Including 19,000 cases,
the European pilot audit has created the biggest
database on acute exacerbation so far (Fig. 3). The
aim of the audit is to create awareness of inequali-
ties of COPD management in different European
countries and start a discussion about improving
the standards of care by learning from each other
and comparing individual hospital data with the
national and the European standard. The evalu-
ation of the clinical treatment standards was ba-
sed on the evidence-based recommendations of the
GOLD Committee [7], and the organisation of care
was evaluated for technical equipment and the
provision of medical professionals in numbers and
specialisation.
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Figure 1. Global risks report 2011, World Economic Forum
the audit allow the treatment to be benchmarked
to the predicted success of controlled studies. High
readmission rates within 3 months (35%) in most
European countries are one of the alarming results
The approach is observational, aiming for the
reflection of real life practice of the treatment of
COPD exacerbation during hospital admission.
Outcome data from such observational project like
Figure 2. Abstract 400 ERS Congress 2011: Sylvia Hartl, Jose Lopez-Campos, Mike Roberts Diagnosis of COPD exacerbations on hospital
admission: Results from the European COPD audit
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that indicate a need for improved management.
Guideline recommendations concentrate on proper
diagnosis of stable disease and recommend treat-
ment standards for exacerbation based on the as-
sumption of diagnosed COPD. Around 40% of pa-
tients on acute (emergency) admission do not know
any lung function results and are treated as COPD
exacerbation based on the clinical judgement of a
senior physician. Such findings together with the
high proportion of current smokers reveal obvio-
us deficiencies in education of COPD patients in
all European countries. Clearly the collection of
data in a clinical setting retrieved from clinical
records has weaknesses in terms of multifactorial
biases that are less well controlled than in rando-
mised controlled trials (RCT). On the other hand,
looking at the whole group of patients treated as
COPD exacerbations reflects a wider cohort than
the selected group of controlled trials and delivers
complementary information to the findings of
RCTs. The methodology of the European audit is
published elsewhere [8], and audit reports have
been created analysing the median distribution of
results in Europe (the European COPD Audit Re-
port is available at ersnet.org) and 822 national
Figure 3. Abstract 400 ERS Congress 2011: Sylvia Hartl, Jose Lopez-Campos, Mike Roberts; Diagnosis of COPD exacerbations on hospital
admission: Results from the European COPD audit
audit reports comparing participating hospital data
with their national median values and the median
European values. Hospital identities are anonymi-
sed (unless the report to the individual hospitals)
because an audit project is not intending to create
rankings of hospitals according to excellence but
wants to investigate reasons of disparities and in-
duce changes of individual COPD-management of
single hospitals or countries.
It is of upmost importance now that the most
striking findings of the analysis of the reports are
discussed in the light of underlying conditions: this
will not only focus on the differences in patient
disease severity, including comorbidities in diffe-
rent European countries, but also look at the in-
fluence of the availability of treatment options on
the delivery of care. Noninvasive ventilation (NIV)
equipment, for instance, is provided very dispro-
portionally in different countries, leading to varia-
ble access of acidotic patients to NIV. Comparing
such findings to the current evidence of predicted
outcome in terms of length of stay and hospital
mortality reveals that the quality of care depends
very much on which hospital setting
a patient is admitted.
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Publication of the data at the national level
will enhance the effect of the results, spreading it
to national health authorities. International orga-
nisations like patient organisations, EU-research
organisations, or the WHO might be interested in
the European inequalities of care and may support
the audit technique as an assessment tool of qu-
ality of care but have less influence on rapid chan-
ges of delivery of care at individual hospital level.
The potential of the first European COPD Au-
dit pilot study is a unique chance to create a network
of hospitals dedicated to improve their quality of
care by learning from their results and measure their
success in another audit after some years. This will
lead to improved questions, evaluation of unmet
needs of our patients, and contribution to future gu-
idelines in terms of implementation strategies of
quality of care. The resulting activity at a national
level for improved standards depends on how he-
alth care is organised within a certain country ac-
cording to the regional health care services. The
European audit will not be able to make judgements
about better or worse health care organisation as this
needs to be analysed in context with the catchment
population a hospital is serving as well as how pre-
hospital services are established. Nevertheless, in
total, a general impression of the distribution of out-
comes in Europe can be estimated and relevant de-
viations of treatment recommendations will be iden-
tified. Nationwide, the inequality of care can be in-
terpreted more easily as the health care system is ap-
plicable to all cases and expected provision of care
from primary to tertiary care centres is defined.
We need to encourage all participating nations
to deliver their analysis and come together for Eu-
ropean conferences to discuss the results of best
practice or deficiencies within their country in the
light of fuzzy logic techniques to relate the effects
of similar findings to the impact of identification
of best practice models [9].
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